Orexigen's Contrave diet pill awaits FDA approval, could be an obesity fighting medicine

June 10, 2014 9:05 PM

23 0

Orexigen is hoping that additional trials of its weight loss drug will be a winner for the FDA. It awaits approval after years of testing.(Photo : Orexigen)

A new diet pill is angling for approval from the Food and Drug Administration and has many observers waiting patiently to see if the federal agency will allow the weight loss drug NB32 from Orexigen onto the market. It comes as obesity and weight issues remain a top health issue in the United States...

Read more

To category page